Erlonat (erlotinib), manufacturer: natco
Erlonat (erlotinib) is essentially used to treat cell lung disease, or pancreatic tumor when joined with a specific other solution. It works by restraining development to neighboring tissues in the body so the malignant cells back off, permitting the patient a superior situation to recoup and battle the growth normally.
Dose and administration :
Ordinarily, a grown-up patient will be told to take in the vicinity of 100mg and 150mg of erlonat (erlotinib), no less than 1 hour before any dinners or tidbits and 2 hours after. Unless generally trained, you ought to dependably gulp down every tablet without biting, pounding, part, or dissolving the tablet in fluid. Wash tablets down with full glass of water.
Indications are coughing, fever, weakness, chest torments ,severe or persevering nausea, vomiting, diarrhea, eye discomfort, irritated or dry skin, inward developing eyelashes, unusual wounding or bleeding, loss of hunger
Packaging : 150 mg tablet 30 tablets
Manufactured By : NATCO
Product Name : | Erlonat |
Contains : | Erlotinib hydrochloride |
Form : | Tablet |
Strength : | 100 mg & 150 mg |
Packing : | Pack Of 30 Tabs |